1492 Capital Management LLC Corcept Therapeutics Inc Transaction History

1492 Capital Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 14, 2018	SELL	$12.27 - $15.65 $790,543 - $1.01 Million	-64,429 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$15.3 - $19.69 $1,147 - $1,476	-75 Reduced 0.12%	64,429 $1.01 Million
Q1 2018 May 14, 2018	SELL	$14.59 - $25.5 $77,735 - $135,864	-5,328 Reduced 7.63%	64,504 $1.06 Million
Q4 2017 Feb 14, 2018	SELL	$15.77 - $20.72 $3,185 - $4,185	-202 Reduced 0.29%	69,832 $1.26 Million
Q3 2017 Nov 09, 2017	BUY	$12.3 - $19.3 $861,418 - $1.35 Million	70,034	70,034 $1.35 Million

316

93.8M

2.02M

3.24M

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $3.22B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

Get notified when there are updates to the investment portfolio of 1492 Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on 1492 Capital Management LLC with notifications on news.